§ Funding Round
Angitia Biopharmaceuticals raised $46M Series B Plus venture round, led by Morningside Ventures.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
Morningside VenturesLEAD | — | — |
| Organization | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$336M
Top Valuation
-
Angitia Biopharmaceuticals raised $46M in a Series B Plus round.
The round was announced on 10/25/23.
The round was led by Morningside Ventures.
